Literature DB >> 19558501

Neuroendocrine activity of the melanocyte.

Andrzej Slominski1.   

Abstract

More than 15 years ago, we have proposed that melanocytes are sensory and regulatory cells with computing capability, which transform external and/or internal signals/energy into organized regulatory network(s) for the maintenance of the cutaneous homeostasis. This concept is substantiated by accumulating evidence that melanocytes produce classical stress neurotransmitters, neuropeptides and hormones, express corresponding receptors and these processes are modified and/or regulated by ultraviolet radiation, biological factors or stress. Examples of the above are catecholamines, serotonin, N-acetyl-serotonin, melatonin, proopiomelanocortin-derived adrenocorticotropic hormone, beta-endorphin or melanocyte-stimulating hormone peptides, corticotropin releasing factor, related urocortins and corticosteroids including cortisol and corticosterone as well as their precursors. Furthermore, their production is not random, but hierarchical and follows the structures of classical neuroendocrine organizations such as hypothalamic-pituitary-adrenal axis, serotoninergic, melatoninergic and catecholaminergic systems. An example of an intrinsic but overlooked neuroendocrine activity is production and secretion of melanogenesis intermediates including l-DOPA or its derivatives that could enter circulation and act on distant sites. Such capabilities have defined melanocytes as neuroendocrine cells that not only coordinate cutaneous but also can affect a global homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558501      PMCID: PMC2773661          DOI: 10.1111/j.1600-0625.2009.00892.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  66 in total

1.  What's the use of generating melanin?

Authors:  J M Wood; K Jimbow; R E Boissy; A Slominski; P M Plonka; J Slawinski; J Wortsman; J Tosk
Journal:  Exp Dermatol       Date:  1999-04       Impact factor: 3.960

2.  Tryptophan hydroxylase expression in human skin cells.

Authors:  Andrzej Slominski; Alexander Pisarchik; Olle Johansson; Chen Jing; Igor Semak; George Slugocki; Jacobo Wortsman
Journal:  Biochim Biophys Acta       Date:  2003-10-15

Review 3.  Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology.

Authors:  Markus Böhm; Thomas A Luger; Desmond J Tobin; José Carlos García-Borrón
Journal:  J Invest Dermatol       Date:  2006-09       Impact factor: 8.551

Review 4.  Human skin pigmentation: melanocytes modulate skin color in response to stress.

Authors:  Gertrude-E Costin; Vincent J Hearing
Journal:  FASEB J       Date:  2007-01-22       Impact factor: 5.191

Review 5.  Neuroendocrinology of the skin.

Authors:  A Slominski; J Wortsman
Journal:  Endocr Rev       Date:  2000-10       Impact factor: 19.871

6.  Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis.

Authors:  Karine Rousseau; Sobia Kauser; Lynn E Pritchard; Anne Warhurst; Robert L Oliver; Andrzej Slominski; Edward T Wei; Anthony J Thody; Desmond J Tobin; Anne White
Journal:  FASEB J       Date:  2007-02-22       Impact factor: 5.191

7.  A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.

Authors:  Andrzej Slominski; Jordan Zjawiony; Jacobo Wortsman; Igor Semak; Jeremy Stewart; Alexander Pisarchik; Trevor Sweatman; Josep Marcos; Chuck Dunbar; Robert C Tuckey
Journal:  Eur J Biochem       Date:  2004-11

Review 8.  Towards defining receptors for L-tyrosine and L-dopa.

Authors:  A Slominski; R Paus
Journal:  Mol Cell Endocrinol       Date:  1994-03       Impact factor: 4.102

9.  L-tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells.

Authors:  A Slominski; G Moellmann; E Kuklinska
Journal:  Pigment Cell Res       Date:  1989 Mar-Apr

10.  Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC.

Authors:  A Slominski
Journal:  Exp Dermatol       Date:  1998-08       Impact factor: 3.960

View more
  59 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 2.  Skin, reactive oxygen species, and circadian clocks.

Authors:  Mary A Ndiaye; Minakshi Nihal; Gary S Wood; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2013-11-21       Impact factor: 8.401

Review 3.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

4.  5-HT receptors as novel targets for optimizing pigmentary responses in dorsal skin melanophores of frog, Hoplobatrachus tigerinus.

Authors:  Sharique A Ali; Saima Salim; Tarandeep Sahni; Jaya Peter; Ayesha S Ali
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Neuroendocrinology of the skin: An overview and selective analysis.

Authors:  Michal A Zmijewski; Andrzej T Slominski
Journal:  Dermatoendocrinol       Date:  2011-01

6.  Skin under the sun: when melanin pigment meets vitamin D.

Authors:  Andrzej Slominski; Arnold E Postlethwaite
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

7.  Structural changes in thestrial blood-labyrinth barrier of aged C57BL/6 mice.

Authors:  Lingling Neng; Jinhui Zhang; Ju Yang; Fei Zhang; Ivan A Lopez; Mingmin Dong; Xiaorui Shi
Journal:  Cell Tissue Res       Date:  2015-03-05       Impact factor: 5.249

8.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

9.  Targeting ALDH1A1 to treat pigmentary disorders.

Authors:  Konrad Kleszczynski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2013-05       Impact factor: 3.960

Review 10.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.